SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-004842
Filing Date
2024-08-14
Accepted
2024-08-14 16:20:12
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1382556
2 CERTIFICATION vnrx_ex311.htm EX-31.1 9801
3 CERTIFICATION vnrx_ex312.htm EX-31.2 9886
4 CERTIFICATION vnrx_ex321.htm EX-32.1 4944
  Complete submission text file 0001477932-24-004842.txt   6668436

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20240630.xsd EX-101.SCH 79408
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20240630_lab.xml EX-101.LAB 376957
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20240630_cal.xml EX-101.CAL 54770
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20240630_pre.xml EX-101.PRE 342165
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20240630_def.xml EX-101.DEF 231428
75 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 1145153
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 241208271
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)